Pulmonary fibrosis (PF) is characterized by aberrant extracellular matrix (ECM) deposition,
activation of fibroblasts to myofibroblasts and parenchymal disorganization, which have an …

Background Idiopathic pulmonary fibrosis (IPF) is a chronic progressively fatal disease.
Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) is a glycosylated transmembrane …

ABSTRACT CD147, also known as extracellular matrix metalloproteinase inducer
(EMMPRIN) or basigin, is expressed in a variety of cell types. It is involved in the regulation …

Idiopathic pulmonary fibrosis (IPF) is a restrictive lung disease that is associated with high
morbidity and mortality. Current medical therapies are not fully effective at limiting mortality …

Idiopathic pulmonary fibrosis (IPF) is a progressive and devastating lung disorder of
unknown origin, with very poor prognosis and no effective treatment. The disease is …

Idiopathic pulmonary fibrosis (IPF) is a debilitating condition where excess collagen
deposition occurs in the extracellular matrix. At first sight, it is expected that the level of …

Rationale Idiopathic pulmonary fibrosis (IPF) is a fatal disease characterized by excessive
deposition of extracellular matrix (ECM). Objectives We investigated the regulation of matrix …

Background Idiopathic pulmonary fibrosis (IPF) is a diffuse parenchymal lung disease
characterized by exuberant deposition of extracellular matrix (ECM) proteins in the lung …

Idiopathic pulmonary fibrosis (IPF) may be triggered by epithelial injury that results in
aberrant production of growth factors, cytokines, and proteinases, leading to proliferation of …

Lung fibrosis is the final common pathway of a large variety of chronic lung disorders,
named interstitial lung diseases. The most aggressive form is the idiopathic pulmonary …